Interna onal Union Against Tuberculosis and Lung Disease
Health solu ons for the poor VOL 3 NO Setting: A rural paediatric hospital in Bo, Sierra Leone. Objectives: To assess the level of adherence to standard treatment guidelines among clinicians prescribing treatment for children admitted with a diagnosis of malaria and/or lower respiratory tract infection (LRTI), and determine the association between (non) adherence and hospital outcomes, given that non-rational use of medicines is a serious global problem. Design: Secondary analysis of routine programme data. Results: Data were collected for 865 children admitted with an entry diagnosis of malaria and 690 children with LRTI during the period January to April 2011; some patients were classified in both categories. Non-adherence to guidelines comprised use of non-standard drug regimens, dosage variations, non-standard frequency of administration and treatment duration. Cumulative non-adherence to guidelines for LRTI cases was 86%. For malaria, this involved 12% of patients. Potentially harmful non-adherence was significantly associated with an unfavourable hospital outcome, both for malaria and for LRTI cases.
Conclusions:
Overall non-adherence to standard treatment guidelines by clinicians in a routine hospital setting is very high and influences hospital outcomes. This study advocates for the implementation of routine measures to monitor and improve rational drug use and the quality of clinical care in such hospitals.
N on-rational use of medicines is a huge global problem. 1 It may have serious consequences in terms of poor patient outcome, adverse drug reactions, increasing antimicrobial resistance and wasted resources. Rational use of medicines requires that patients take medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time and at the lowest cost to themselves and their community. 2 Standard treatment guidelines are designed to ensure that medications are administered in a safe, effective and economic manner, and are very powerful tools in promoting the rational use of medicines. Standard treatment guidelines help prescribers make decisions about appropriate treatments for specifi c clinical conditions. When medicines are not prescribed in accordance with standard treatment guidelines, it constitutes non-rational use of medicines. 3, 4 In developing countries, the proportion of patients treated according to clinical standard treatment guidelines in primary care is less than 40% in the public sector and 30% in the private sector. 1 For hospital set-with an acceptable error margin of 10%), treatment frequency (number of administrations per day) and treatment duration (number of days of treatment). If one of the above conditions was not met, the prescription was classifi ed as 'non-adherent to standard treatment guidelines'. The standard guidelines in use are shown in Figure 1 and Tables 1 and 2 .
Potentially harmful non-adherence
Prescriptions classifi ed as 'non-adherent to standard treatment guidelines' were assessed for their potential harmfulness. Drug regimen and duration were included in this assessment. A potentially harmful regimen was defi ned as 'no treatment prescribed; or treatment prescribed without any antimalarial agent (for a malaria-positive case) or without any antibiotic (for an LRTI case)'. A potentially harmful duration was defi ned as an antimalarial agent (artesunate-amodiaquine) prescribed for <2 days (for the malaria population) or an antibiotic (amoxicillin or gentamicin) prescribed for <5 days (for the LRTI population). If either regimen or duration were categorised as potentially harmful, the prescription was classifi ed as potentially harmful non-adherence to guidelines. The association with hospital outcome (death or loss to follow-up) was examined. Potential drug toxicity (dosage and frequency) was not included in the assessment of potentially harmful non-adherence.
Variables, data collection and analysis
Records of all anti-infective treatment regimens for malaria and LRTI prescribed in the fi rst 24 h after admission were entered into an Excel database (Microsoft, Redmond, WA, USA) and data entry fi le developed using EpiData Entry software version 2.2.1.171 (EpiData Association, Odense, Denmark). Data validation of the Excel database involved 100% double checking of entered data by a second person.
The characteristics of the treatment prescribed (type of drug, duration of treatment) depend on the severity of the disease. Severity of disease was assessed based on clinical parameters available in the case fi les. Variables collected included admission number, patient characteristics (sex, age, weight), treatment characteristics (dose, frequency and duration of anti-infectives prescribed in the fi rst 24 h), a set of clinical parameters (respiratory rate, chest in-drawing [intercostal recession], malaria rapid diagnosis test [paracheck] result, haemoglobin, convulsions, assessment of impaired consciousness, inability to drink, shock). Results were recorded as positive (present), negative (not present) or not recorded.
Data screening for possible non-adherence was performed by an automated search algorithm. Cases fl agged as possibly nona dherent were audited independently by two general practitioners. In case of discordance between the two clinicians, a fi nal judgment was made by an experienced paediatrician. Non-adherent cases were classifi ed as potentially harmful according to the above defi nition.
Ethics
Ethics approval was obtained from the Sierra Leone Ethics and Scientifi c Review Committee. This study also met the MSF Ethics Review Board-approved criteria for analysis of routinely collected programme data and was approved by the Ethics Advisory Group of the International Union Against Tuberculosis and Lung Disease, Paris, France.
RESULTS

Characteristics of the study population
Data on study subjects with an entry diagnosis of malaria and/or LRTI were extracted from 1602 case fi les for the period January to April 2011. Of the total 1602 case fi les, 865 patients (54%) had an entry diagnosis of malaria and 690 (43%) LRTI; some patients (n = 308) were classifi ed in both categories, as both pathologies were diagnosed at the time of admission. The remaining 355 patients had an entry diagnosis other than malaria or LRTI.
Based on the set of clinical parameters assessed, at least 530 (61%) of the malaria cases and at least 514 (74%) of the LRTI cases were classifi ed as severe. The LRTI population included 296 (43%) females and the median age was 11 months (interquartile range 
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[IQR] 6-21). The malaria population included 377 (44%) females; the median age was 24 months (IQR 12-36).
Prescription characteristics
A total of 864 anti-malarial treatments were prescribed for the 865 patients admitted with malaria, the most frequent being artemether (73%), followed by the co-formulation artesunate/ amodiaquine (14%) and quinine (13%). Some children did not receive a prescription, while others received multiple anti-malarial prescriptions (e.g., artemether loading dose, followed by artesunate/ amodiaquine). The 690 patients admitted with LRTI were prescribed 1141 antibiotic treatments in total, consisting of gentamicin (45%) and ampicillin (44%), and to a lesser extent amoxicillin (3%), ceftriaxone (1%) or other antibiotics (6%). As combined intravenous (IV) or intramuscular (IM) ampicillin and gentamicin IM are the fi rstline treatment for pneumonia in children aged 2 months-5 years, the majority of the LRTI patients (73%) were prescribed two a ntibiotics per patient in the fi rst 24 h following admission. The remaining LRTI patients were prescribed 0 (15%), 1 (8%), 3 (3%) or 4 (0.4%) antibiotics within the fi rst 24 h of admission. Table 3 shows the overall cumulative level of case fi les non-adherent to standard treatment guidelines. Treatment of some patients was non-adherent to more than one aspect of the guidelines (regimendosage-frequency-duration). Overall adherence to guidelines proved to be a bigger problem for LRTI cases, with 590 (86%) case fi les being non-adherent to at least one element of the guidelines, compared to 105 (12%) of the malaria case fi les. Non-adherence to regimen, dosage, frequency and duration were persistently higher for LRTI case fi les than malaria case fi les. Furthermore, overall non-adherence appeared to be higher in children aged ⩾5 years, for both malaria and LRTI cases. Detailed analysis indicated that among non-adherent malaria cases, potential harm could have been caused in 48 (46%) cases. For LRTI, the potential for harm was identifi ed in 104 of 590 (18%) cases with non-adherence. Table 4 shows the number of non-adherent prescriptions (individual drugs) for the above patients, stratifi ed by dosage (detailed analysis also shown in Figures 2 and 3) , frequency of administration and treatment duration. As evidenced, the three main problems for malaria involved no treatment being prescribed for 43 (5%) patients, incorrect treatment in 29 (3.4%) and over-dosage in 20 (2.3%). In case of LRTI, the main problems were excessively short treatment duration time for 399 (34.9%) patients, over-dosage in 139 (12.2%) and no treatment being prescribed for 91 (13.2%).
Non-adherence to standard treatment guidelines
Potentially harmful non-adherence
We assessed the putative association between an unfavourable hospital outcome (defi ned as death or loss to follow-up) and potentially harmful non-adherence to standard treatment guidelines (Table 5 ). Harmful non-adherence was signifi cantly associated with an unfavourable outcome for both malaria and LRTI cases. This association was signifi cant for prescription of an incorrect drug regimen; for potentially harmful non-adherent treatment duration, no association was observed.
TABLE 3
Overall guideline non-adherence and types of non-adherence to standard treatment guidelines for children (age <15 years) admitted to Gondama Hospital, Sierra Leone, January-April 2011
Patients with an initial diagnosis of malaria (n = 865)
Patients with an initial diagnosis of LRTI (n = 690) 
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DISCUSSION
To the best of our knowledge, this is the fi rst published study to assess the level of non-adherence to standard treatment guidelines by clinicians in a rural hospital setting in Africa. It shows a high level of non-adherence, the consequences of which could, at the very least, include adverse drug reactions, increasing antimicrobial resistance and poorly planned/wasted resources. In addition, an association was found between non-adherence, classifi ed as potentially harmful, and unfavourable hospital outcomes of patients (deaths and losses to follow-up), suggesting that nonadherence to standard guidelines has a direct and detrimental effect on the quality of hospital care. The strengths of the study are that 1) this assessment involved routine operational data, and the fi ndings are thus likely to refl ect clinical reality on the wards; 2) this is, as far as we know, one of the fi rst published studies to assess adherence to standard treatment guidelines in a hospital setting; and 3) adherence was assessed independently by three experienced clinicians.
The study limitations are that our assessment was based purely on audits of case fi les and as such, under-reporting and errors in case fi les could have been sources of bias. For example, we were unable to verify whether the 13% of LRTI cases and 5% of malaria cases who were indicated as not having been prescribed treatment represent a genuine problem of no prescription or a recording error in the case fi les.
Moreover, based on the set of clinical parameters assessed, at least 61% of the malaria cases and at least 74% of the LRTI cases were classifi ed as severe. Some severe cases may have been missed, as not all clinical variables could be collected, and these numbers therefore present the absolute minimum of severe cases. We also observed that patterns of non-adherence differed considerably FIGURE 2 Histogram: deviation from guidelines in prescribing daily dosages of anti-LRTI drugs, Gondama Hospital, Sierra Leone. LRTI = lower respiratory tract infection.
FIGURE 3
Histogram: deviation from guidelines in prescribing daily dosages of anti-malaria drugs, Gondama Hospital, Sierra Leone.
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Non-adherence to guidelines in a hospital setting 123 b etween regimens: this would merit drug-specifi c analysis, which was outside the scope of this study. Finally, entry and exit dates were not collected for the patients included in the study; any effects of prescription non-adherence on length of hospital stay could therefore not be assessed. We could also not assess whether the negative outcomes associated with absence of treatment occurred early after hospitalisation and were thus the cause of the absence of treatment rather than the consequence. A negative hospital outcome could, in that case, explain the statistically signifi cant association with potentially harmful non-adherence to guidelines. Our fi ndings nevertheless raise a number of issues that merit discussion. First, although we assessed overall non-adherence to be high, with inadequacies being seen in all aspects of prescriptions (drug regimen, dosage, frequency and duration), we do not know how these fi ndings compare with other similar hospital settings due to the paucity of published literature on the subject. There is thus a need for similar studies in busy hospitals to routinely monitor and report on this important issue.
Second, adherence to a relatively straightforward treatment guideline (that for malaria) was better than that to more complex guidelines (such as those for LRTI). This might be related to the fact that malaria treatment is more standardised, there are fewer drug options than for LRTI and, as artemisinin-based combinations are used, monitoring of drug use is more rigorous. These factors may have restricted clinician fl exibility in prescribing.
Third, the MSF diagnostic and treatment guidelines are well standardised. 5 This manual is designed to respond in the simplest and most practical way possible to managing diseases by fi eld medical staff. It is based on many years of MSF fi eld experience, and is in line with World Health Organization (WHO) recommendations. 4 From a public health and operational perspective, such standardisation is required as it facilitates the development of treatment guidelines, allows standardisation in training curricula-which also makes staff training easier, and facilitates drug forecasting. The disadvantage of such standardisation is that it introduces a form of rigidity. As such, our study based on the existing standard treatment guidelines will not capture nuances based on clinical judgment. For example, although the MSF guidelines recommend 100 mg/kg/day as the dose for an antibiotic such as ampicillin, a clinician could justifi ably raise this to 200 mg/kg/ day or more based on the severity of the child's condition.
We are therefore likely to have overestimated 'incorrect' or non-rational use, as we considered any deviation from standard treatment guidelines to be non-rational. However, the problems we observed, such as no treatment having been recorded and variations in the frequency of administration and duration of treatment, are not subject to such clinical fl exibility. One explanation for this could be that the Bo Hospital is staffed by doctors and senior clinicians who often rely on clinical judgment and are thus less adherent to treatment guidelines. For example, in Benin, higher percentages of children with diarrhoea received oral rehydration therapy, and more children with fever were appropriately treated with a recommended antimalarial drug by nursing aides than by nurses (intermediate) or physicians (worst performance). 6, 7 Furthermore, coordination staff, who are often junior clinicians, might feel reluctant to advise their more senior colleagues on prescription practice, as this is traditionally not done in medical practice. One way of tackling this problem would be to introduce regular auditing and reporting of rational drug use at monthly or quarterly hospital clinical meetings and open discussions between clinical staff, during which deviations from the protocol are explained. Non-adherence to guidelines might be justifi ed in some cases, but clinicians should be expected to justify their actions when deviating from protocol.
Finally, urgent measures need to be undertaken in the hospital setting to improve current prescription practices. Evidence and experience suggest that inappropriate training on the existing curriculum, poor supervision and weak regulatory mechanisms affect the quality of care provided by any cadre. Examples include the poor ability of medical and nursing graduates in Ghana and Tanzania to deliver quality family practice, 8 and medical assistants persisting with unconventional treatment patterns after in-service training. 9 A concerted approach is thus needed, involving enhanced training of clinical staff on existing standard treatment guidelines, which should be regularly updated on the basis of new evidence. 10 As staff turnover is high, a system needs to be put in place to ensure that all new staff are systematically briefed on the guidelines, and that regular refresher trainings are conducted. Pocket handbooks highlighting standard treatment guidelines for common diseases might serve as a useful bedside reference tool for clinicians. On a monthly basis, a formal independent evaluation of 10 prescriptions for malaria and LRTI issued by each clinician would also be a way of assessing adherence to guidelines on a continuing basis and providing an alert when needed.
In 1993, the WHO and the International Network for Rational Use of Drugs produced a manual that defi ned core indicators and provided a methodology for measuring these indicators for general out-patients in health facilities. 11 Similar standards do not exist for in-patient settings. We call upon the WHO and partners to establish similar indicators to measure pharmaceutical use by hospital in-patients, where medicine use patterns are far more complex.
In conclusion, this study highlights an important undera ddressed problem in routine hospital care and advocates for the implementation of routine measures to monitor and improve rational drug use. Conclusions : Globalement, la non-adhésion aux directives par les cliniciens dans un contexte hospitalier de routine est très élevée et a une influence sur les résultats obtenus à l'hôpital. L'étude plaide en faveur de la mise en oeuvre de mesures de routine pour suivre et amé-liorer l'utilisation rationnelle des médicaments ainsi que la qualité des soins cliniques dans ces hôpitaux.
Marco de referencia:
Un hospital pediátrico en la zona rural de Bo, en Sierra Leona. Objetivos: Evaluar la observancia de las directrices de tratamiento normalizado por parte de los médicos que deciden el tratamiento de los niños hospitalizados con diagnóstico de malaria o infecciones de las vías respiratorias inferiores (LRTI) y se determinó la asociación entre el incumplimiento de las normas y los desenlaces clínicos en el momento del alta hospitalaria, visto que la utilización incorrecta de los medicamentos constituye un grave problema a escala mundial. Métodos: Se llevó a cabo un análisis secundario de los datos corrientes del programa. Resultados: Se recogieron los datos de los niños hospitalizados e ntre enero y abril del 2011 con diagnóstico de ingreso de malaria en 865 casos y de LRTI en 690 casos; algunos pacientes se clasificaron en ambas categorías. El incumplimiento de las directrices consistió en el uso de un régimen terapéutico diferente o en la modificación de las dosis terapéuticas, la frecuencia de administración o la duración del tratamiento. El incumplimiento acumulado de las directrices relacionadas con las LRTI fue de 86%. En los casos de malaria, se encontró una falta de observancia en el 12% de los casos. Se observó que un incumplimiento terapéutico posiblemente nocivo se asocia de manera significativa con desenlaces hospitalarios desfavorables en ambas enfermedades. Conclusiones: En general, el estudio puso en evidencia un alto grado de incumplimiento médico con las directrices de tratamiento normalizado en un entorno hospitalario corriente, con repercusiones notables en los desenlaces de la hospitalización. Se promueve la introducción de medidas sistemáticas que permitan supervisar y mejorar la utilización de los medicamentos y asegurar la calidad de la atención clínica en estos entornos hospitalarios.
